Multiple-Dose Pharmacokinetics of Atrasentan, an Endothelin-A Receptor Antagonist

By Dutta S.  

Clinical Drug Investigation, Vol. 21, Iss. 2, 2001-02 ,pp. : 129-136

Adis International

Access to resources Recommend Favorite

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

By Horn Evelyn M   Widlitz Allison C   Barst Robyn J  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1483-1492

Informa Healthcare

Access to resources Recommend Favorite

Heart failure and endothelin receptor antagonists

By Miyauchi T.   Goto K.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 5, 1999-05 ,pp. : 210-217

Elsevier

Access to resources Recommend Favorite

ZD1611, an Orally Active Endothelin-A Receptor Antagonist, Prevents Chronic Hypoxia-induced Pulmonary Hypertension in the Rat

By Bialecki R.A.   Fisher C.S.   Abbott B.M.   Barthlow H.G.   Caccese R.G.   Stow R.B.   Rumsey J.   Rumsey W.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 5, 1999-10 ,pp. : 303-312

Academic Press

Access to resources Recommend Favorite

Endothelin Receptor Antagonists in Heart Failure: Current Status and Future Directions

By Ertl G.   Bauersachs J.  

Drugs, Vol. 64, Iss. 10, 2004-01 ,pp. : 1029-1040

Adis International

Access to resources Recommend Favorite